microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway

References

• Chedid MF, Kruel CRP, Pinto MA, et al. Hepatocellular carcinoma: diagnosis and operative management. Arq Bras Cir Dig. 2017;30(4):272–278. doi:10.1590/0102-6720201700040011
   PubMed Web of Science ®Google Scholar
• Rastogi A. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):4000–4013. doi:10.3748/wjg.v24.i35.4000
   PubMed Web of Science ®Google Scholar
• Wang Z, Shi Z, Zhang L, et al. Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinoma. Pathol Res Pract. 2019;215(3):499–505. doi:10.1016/j.prp.2018.12.012
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo X, Li Z, et al. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. RNA Biol. 2015;12(6):643–657. doi:10.1080/15476286.2015.1022702
   PubMed Web of Science ®Google Scholar
• Qin L, Huang J, Wang G, et al. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma. J Cell Physiol. 2019;234(12):23581–23595. doi:10.1002/jcp.28927
   PubMed Web of Science ®Google Scholar
• An Y, Gao S, Zhao WC, et al. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World J Gastroenterol. 2018;24(24):2596–2604. doi:10.3748/wjg.v24.i24.2596
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen T, Lin Q, et al. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer. J Surg Oncol. 2013;107(7):767–771. doi:10.1002/jso.23312
   PubMed Web of Science ®Google Scholar
• Jiang XM, Yu XN, Liu TT, et al. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma. Biomed Pharmacother. 2018;105:1147–1154. doi:10.1016/j.biopha.2018.06.097
   PubMed Web of Science ®Google Scholar
• Qian YY, Liu ZS, Zhang Z, et al. Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma. Mol Med Rep. 2018;17(4):5193–5201. doi:10.3892/mmr.2018.8515
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang W, Chang W, et al. MicroRNA-376c-3p facilitates human hepatocellular carcinoma progression via repressing AT-rich interaction domain 2. J Cancer. 2018;9(22):4187–4196. doi:10.7150/jca.27939
   PubMed Web of Science ®Google Scholar
• Sanchez-Mejias A, Kwon J, Chew XH, et al. A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer. Int J Cancer. 2019;144(2):311–321. doi:10.1002/ijc.31857
   PubMed Web of Science ®Google Scholar
• Hagiwara N. Sox6, jack of all trades: a versatile regulatory protein in vertebrate development. Dev Dyn. 2011;240(6):1311–1321. doi:10.1002/dvdy.22639
   PubMed Web of Science ®Google Scholar
• Guo X, Yang M, Gu H, et al. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Cancer Epidemiol. 2013;37(5):732–736. doi:10.1016/j.canep.2013.05.002
   PubMed Web of Science ®Google Scholar
• Fittipaldi S, Vasuri F, Bonora S, et al. miRNA signature of hepatocellular carcinoma vascularization: how the controls can influence the signature. Dig Dis Sci. 2017;62(9):2397–2407. doi:10.1007/s10620-017-4654-3
   PubMed Web of Science ®Google Scholar
• Sun HX, Yang ZF, Tang WG, et al. MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma. J Cancer. 2020;11(9):2476–2484. doi:10.7150/jca.37748
   PubMed Web of Science ®Google Scholar
• Wang G, Dong F, Xu Z, et al. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. BMC Cancer. 2017;17(1):805. doi:10.1186/s12885-017-3816-1
   PubMed Web of Science ®Google Scholar
• Hung PS, Chen CY, Chen WT, et al. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLoS One. 2017;12(5):e0177346. doi:10.1371/journal.pone.0177346
   PubMed Web of Science ®Google Scholar
• Li H, Zheng D, Zhang B, et al. Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. J Transl Med. 2014;12(1):196. doi:10.1186/1479-5876-12-196
   PubMed Web of Science ®Google Scholar
• Li YC, Li CF, Chen LB, et al. MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer. Onco Targets Ther. 2015;8:2981–2988. doi:10.2147/OTT.S89459
   PubMed Web of Science ®Google Scholar
• Xie Q, Chen X, Lu F, et al. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer. 2012;118(9):2431–2442. doi:10.1002/cncr.26566
   PubMed Web of Science ®Google Scholar
• Li Z, Wang Y. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Biochem Cell Biol. 2018;96(3):365–371. doi:10.1139/bcb-2017-0183
   PubMed Web of Science ®Google Scholar
• Wang W, Smits R, Hao H, He C. Wnt/beta-catenin signaling in liver cancers. Cancers (Basel). 2019;11(7).
   Web of Science ®Google Scholar
• Dimri M, Satyanarayana A. Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma. Cancers (Basel). 2020;12(2):491. doi:10.3390/cancers12020491
   PubMed Web of Science ®Google Scholar
• Lin M, Lei T, Zheng J, et al. UBE2S mediates tumor progression via SOX6/beta-catenin signaling in endometrial cancer. Int J Biochem Cell Biol. 2019;109:17–22. doi:10.1016/j.biocel.2019.01.014
   PubMed Web of Science ®Google Scholar
• Leow SC, Poschmann J, Too PG, et al. The transcription factor SOX6 contributes to the developmental origins of obesity by promoting adipogenesis. Development. 2016;143(6):950–961. doi:10.1242/dev.131573
   PubMed Web of Science ®Google Scholar
• Kureel J, John AA, Prakash R, Singh D. MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation. J Cell Biochem. 2018;119(4):3293–3303. doi:10.1002/jcb.26490
   PubMed Web of Science ®Google Scholar
• Yu FB, Sheng J, Yu JM, et al. MiR-19a-3p regulates the forkhead box F2-mediated Wnt/beta-catenin signaling pathway and affects the biological functions of colorectal cancer cells. World J Gastroenterol. 2020;26(6):627–644. doi:10.3748/wjg.v26.i6.627
   PubMed Web of Science ®Google Scholar